HSBC Holdings’s Sanofi SNY Stock Holding History

HSBC Holdings’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-36	Closed	-$2K	–	1765
2013 Q2	$2K	Buy	+36	New	+$1.92K	﹤0.01%	1540

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

HSBC Holdings's SNY Position: Q1 2026 in Review

HSBC Holdings reduced its Sanofi (SNY) stake by 48% in Q1 2026, selling an estimated $4.58M and leaving 107,689 shares worth $5.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

HSBC Holdings first reported a position in SNY in Q2 2013 and has held it in 39 quarters since. The position peaked at $29.5M in Q4 2022. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

HSBC Holdings held 107,689 shares of Sanofi worth $5.22M as of Q1 2026.
HSBC Holdings sold 98,228 Sanofi shares in Q1 2026, an estimated $4.58M.
Sanofi made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1150 holding.
HSBC Holdings first reported a position in Sanofi in Q2 2013 and has held it in 39 quarters since.
HSBC Holdings's Sanofi position peaked at $29.5M in Q4 2022.
738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.